Learning to Understand Cancer Better

+41 76 370 73 25

vanya@loroch.ch

Vanya-Loroch-Logo_inverted

Oncology for non-oncologists

Course Highlights:

  • What makes a cell alive and healthy
  • How are cancer cells different
  • Birth, life and death of human cells
  • The Hallmarks of cancer and the Immune system
  • Carcinogenesis I: from a healthy to a cancer cell
  • Carcinogenesis II: from a cancer cell to disease
  • Self and non-self
  • Innate immunity
  • Adaptive immunity
  • cell-based and humoral immunity
  • Central and peripheral immune tolerance
  • Inflammation
  • Disease-preventing immunity
  • Disease-fighting immunity
  • Disease-healling immunity
  • Immuno-editing: immunosurveillance, equilibrium, escape
  • Cancer preventing immunity and MHC I -antigen presentation
  • Cancer-fighting immunity and MHC2-anitgen presentation
  • Inflammation: a double-edged sword
  • Tumor microenvironment
  • Immunologically hot, cold and depleted tumors
  • From hybridomas to recombinant antibodies
  • Immunodiagnostics in oncology
  • Therapeutic antibodies
  • Antibody-Dependent Cellular Cytotoxicity
  • Complement-Dependent Cytotoxicity
  • Monoclonal antibodies
  • Checkpoint inhibitors
  • CART-cells
  • Adoptive cell transfer therapies
  • Cytokines and adjuvants
  • Cancer vaccines
  • Oncolytic viruses
  • Bi-specific T-cell engagers
  • Combination therapies
  •  Immunotherapy-related Adverse Events
  • Hyper –progressive disease
  • Universal CAR T cells
  • Other CAR cells
  • Oncolytic viruses
  • Predicting efficacy and tumor heterogeneity
  • Cancer immunoprevention

related courses:

Why attend this course?

This two-day course is made for all professionals– scientists and non-scientists- working in oncology that need to gain a through understanding of the transformations that are taking place in cancer treatments thanks to immunotherapy.

Over half-a-century ago, US president Richard Nixon declared the War on Cancer. Many battles have been waged since that day, some were won, many were lost. And then came modern immunotherapies…

Will harnessing the immune system lead to cure against all cancers? No one knows, but immunotherapies are a game changer for more and more patients and the entire oncology enterprise. In a very short time, nearly 4000 drug discovery and development programs in immuno-oncology have been launched…

Is this a challenging development ? Of course. Complex? Certainly.

Fully understandable only by biomedical experts? Certainly not.
Not if you join our course!

Explore Complex Content With Simple Science Stories

Leveraging on our 15 year-long experience in transdisciplinary life science education aimed at busy professionals, this small group course acts as a springboard to explore with confidence all the sciences of immuno-oncology.

It defines with simplicity all the essential notions in biology, oncology and immunology to understand current developments in the field.

It makes the invisible world of disease mechanisms and associated immune responses visible and understandable. It explains the modes of action of all current immunotherapies, the promises they hold but also the concerns and the challenges.

By attending this course you will learn how to discuss key issues in immuno-oncology across all functions.

Who this course is for?

  • All scientists and non-scientists involved in oncology drug development
  • Investors and other enablers of oncology drug pipelines
  • Regulatory Affairs and regulatory science professionals
  • Cancer care providers and caregivers that are non-oncologists
  • Anyone with a strong interest in cancer therapies


This course can be customized to fit the pipeline of any pharma company active in immuno-oncology.